Skip to content

RA PHARMACEUTICALS, INC.

CIK 0001481512

← back to feed
Revenue (TTM)
$3M
+20.0% YoY FY Feb 2020
Net Income (TTM)
−$82.42M
−47.3% YoY FY Feb 2020
EPS Diluted (TTM)
—
FY Feb 2020
Gross Margin
—
FY Feb 2020
Operating Margin
-2,867.7%
FY Feb 2020
Net Margin
-2,747.2%
FY Feb 2020
Free Cash Flow (TTM)
−$88.12M
FY Feb 2020
Cash
$264.99M
FY Feb 2020
Total Debt
—
FY Feb 2020
Shares Outstanding
47.33M sh
FY Feb 2020

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings